Date:June 15, 2026

Kigali, Rwanda — Bio Usawa Biotechnology is pleased to welcome its CEO and President to Kigali as part of the company’s ongoing scientific and operational activities in the region.
Dr. Menghis Bairu is personally on site to observe the offloading process, reflecting Bio Usawa Biotechnology’s hands-on leadership approach and strong commitment to quality, safety, and operational excellence.

Bio Usawa Biotechnology is driven by a mission to advance science-based biotechnology solutions that improve health outcomes and strengthen local and regional capacity.
Through innovation, rigorous scientific standards, and strategic partnerships, the company works to translate advanced biotechnology into sustainable, real-world impact—particularly in emerging and underserved markets.

The visit highlights Bio Usawa Biotechnology’s long-term vision of combining cutting-edge science with responsible implementation to support resilient health systems and expand global access to essential biotechnological solutions.
Bio Usawa, a biotechnology company dedicated to expanding access to high-quality biologic medicines across Africa, today announced the appointment of Dr…
June 2026Prof. Nazik Hammad, Bio Usawa’s Chief Medical Officer for Oncology, recently visited the company’s emerging manufacturing facility in the Kigali Special…
June 2026Bio Usawa will be participating in the 6th Annual African Retina Society (ARS 2026) Conference, taking place on 12–13 June 2026 in Addis Ababa, Ethiopia…
June 2026